Abstract
Much interest has been paid to the use of sedatives and hypnotics during pregnancy, especially after the finding of the strong teratogenic capacity of thalidomide. The pattern of drug use has changed from barbiturates and meprobamates to benzodiazepines, hypnotic benzodiazepine receptor agonists, and some antihistamines. The literature on benzodiazepines is not consistent but the majority of recent studies have not identified any teratogenic effect. It is possible that some benzodiazepines may be teratogens while others are not. In the Swedish data, alprazolam shows up as a possible teratogen with a main effect on cardiovascular defects but few data on this drug exist in the literature. Other specific benzodiazepines may have a teratogenic effect, not present in the most used drugs, e.g., diazepam or oxazepam. There seems to be little reason to suspect teratogenic effects of hypnotic benzodiazepine receptor agonists or the antihistamine drugs used as sedatives or hypnotics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ban L, West J, Gibson JE, Flaschi L, Sokal R, Doyle P, Hubbard R, Smeeth L, Tata LJ. First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study. PLoS One. 2014;9:e100996. https://doi.org/10.1371/journal.pone.0100996.
Bonnot O, Vollset SE, Godet PF, D’Amato T, Robert E. Letter to the editor: maternal exposure to lorazepam and anal atresia in the newborn. Results from a hypothesis-generating study of benzodiazepines and malformations. J Clin Psychopharmacol. 2001;21:456–8.
Einarson A, Bailey B, Jung G, Spizzirri D, Baillie M, Koren G. Prospective controlled study of hydroxyzine and cetirizine in pregnancy. Ann Allergy Asthma Immunol. 1997;78:183–6.
Eros E, Czeizel AE, Rockenbauer M, Sørensen HT, Olsen J. A population-based case-control teratologic study of nitrazepam, medazepam, tofisopam, alprazolam and clonazepam treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2002;101:147–54.
Gidai J, Ács N, Bánhidy F, Czeizel AE. An evaluation of data for 10 children born to mothers who attempted suicide by taking large doses of alprazolam during pregnancy. Toxicol Ind Health. 2008;24:53–60.
Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton, MA: Publishing Sciences Group; 1977.
Källén B, Borg N, Reis M. The use of central nervous system active drugs during pregnancy. Pharmaceuticals. 2013;6:1221–86.
Laegreid L, Olegård R, Conradi N, Hagberg G, Wahlström J, Abrahamsson L. Congenital malformations and maternal consumption of benzodiazepines: a case-control study. Dev Med Child Neurol. 1990;32:432–41.
Laegreid L, Olegård R, Wahlström J, Conradi N. Teratogenic effects of benzodiazepine use during pregnancy. J Pediatr. 1989;114:126–31.
Lenz W. Kindlische Missbildungen nach Medikament-Einahme während der Gravidität? Dtsch Med Wochenschr. 1961;86:2555–6.
McBride WG. Thalidomide and congenital abnormalities. Lancet. 1961;278:1358.
Norstedt Wikner B, Stiller C-O, Bergman U, Asker C, Källén B. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiol Drug Saf. 2007;16:1203–10.
Norstedt Wikner B, Källén B. Are hypnotic benzodiazepine receptor agonists teratogenic in humans? J Clin Psychopharmacol. 2011;31:356–8.
Okun ML, Ebert R, Saini B. A review of sleep-promoting medications use in pregnancy. Am J Obstet Gynecol. 2015;212:428–41.
Rosenberg L, Mitchell MD, Parsells MS, Pashayan H, Louik C, Shapiro S. Lack of relation between oral clefts and use of diazepam during pregnancy. N Engl J Med. 1983;309:1282–5.
Safra JM, Oakley GP Jr. Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet. 1975;2:478–80.
Saxén I, Saxén L. Letter: association between maternal intake of diazepam and oral clefts. Lancet. 1975;2:498.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Källén, B. (2019). Maternal Use of Sedatives or Hypnotics and Infant Congenital Malformations. In: Maternal Drug Use and Infant Congenital Malformations. Springer, Cham. https://doi.org/10.1007/978-3-030-17898-7_26
Download citation
DOI: https://doi.org/10.1007/978-3-030-17898-7_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-17897-0
Online ISBN: 978-3-030-17898-7
eBook Packages: MedicineMedicine (R0)